摘要
心房颤动(房颤)是临床上最常见的持续性心律失常,患病率为1%,其发病人数随着年龄递增。在年龄〉70岁的人群中已达7%~8%,年龄〉80岁可达10%。2003年我国首次房颤大规模流行病学研究表明,中国房颤患病率为0.77%,且随年龄增长而显著增加,年龄〉80岁人群可达7.5%。房颤可引起血栓性脑卒中等严重的并发症。
出处
《中华老年心脑血管病杂志》
CAS
北大核心
2009年第12期922-924,共3页
Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
参考文献17
-
1Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. J AMA, 2001,285: 2370-237:3.
-
2戚文航.中国部分地区心房颤动住院病例回顾性调查[J].中华心血管病杂志,2003,31(12):913-916. 被引量:380
-
3van Walraven C, Robert G, Hart RG, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation an individual patient meta-analysis. J AMA, 2002,288: 2441-24,18.
-
4胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量:163
-
5Lloyd Jones DM, Wang Tj, Leip EP. et al. Lifetime risk for development of atrial fibrillation: The Framingham Heart Study. Circulation,2004, 110 : 1042-1046.
-
6Atrial fibrillation investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med,1994,154:1449-1457.
-
7Research group for antiarrhythmic drug therapy. Risk factors for thromboembolism in patients with atrial fibrillation during treatment with aspirin: a multicenter, cooperative retrospective study. J Cardiol.2000,35:373-379.
-
8Ger DE. Albers GW, Dalen JE, et ak Antithrombotic therapy in atrial fibrillation -The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126: 429S-456S.
-
9Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation-executive summary. Circulation, 2006, 114: 700- 752.
-
10Aronow WS. Management of atrial fibrillation.Compr Ther, 2008,34:134-142.
二级参考文献11
-
1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1407
-
2张学义,张薇,郑兆通,钟明,黎莉,张运.非瓣膜性心房颤动并发缺血性脑卒中的防治[J].中华急诊医学杂志,2004,13(9):592-594. 被引量:21
-
3Arboix A,Lluis GE,Massons JB,et al.Atrial fibrillation and stroke:clinical presentation of cardioembolic versus atherothrombotic infarction.Int J Cardiol,2000,73:33-42.
-
4Petersen P,Boysen G,Godtfredsen J,et al.Placebo controlled,randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation.Lancet,1989,338:175-179.
-
5European Atrial Fibrillation Trial Study Group.Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke.Lancet,1993,342:1255-1262.
-
6Stroke Prevention in Atrial Fibrillation Investigators.Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation:stroke prevention in atrial fibrillation Ⅱstudy.Lancet,1994,343:687-691.
-
7Gullov AL,Koefoed BG,Petersen P,et al.Fixed mini-dose warfarin and aspirin alone and in combination versus adjusted-dose warfarin for stroke prevention in atrial fibrillation:Second Copenhagen Atrial Fibrillation,Aspirin,and Anticoagulation Study.Arch Intern Med,1998,158:1513-1521.
-
8Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia.The European Atrial Fibrillation Trial Study Group.N Engl J Med,1995,333:5-10.
-
9戚文航.中国部分地区心房颤动住院病例回顾性调查[J].中华心血管病杂志,2003,31(12):913-916. 被引量:380
-
10胡大一,孙艺红,周自强,李奎宝,倪永斌,杨光,孙淑红,李蕾.中国人非瓣膜性心房颤动脑卒中危险因素的病例-对照研究[J].中华内科杂志,2003,42(3):157-161. 被引量:362
共引文献520
-
1顾智淳,张在丽,刘晓琰.1例胺碘酮致华法林国际标准化比值升高的病例分析[J].医药导报,2015,34(S01):172-173. 被引量:1
-
2卢建平.96例老年心房颤动患者的临床诊疗体会[J].临床研究,2014,22(11):29-29.
-
3雷礼姣,吴君,冯立娅,彭素文,胡梦颖.门诊药师窗口发放华法林钠对患者用药交待内容的探讨[J].医学信息,2017,30(2):140-141.
-
4滕海英,曹丽霞,贾百全,是明启.非瓣膜病心房颤动致脑栓塞100例临床分析[J].医学信息(医学与计算机应用),2014,0(1):370-370.
-
5王瑶,张劲松,姜丽丽,万芬,陈旭锋,蒋雷.急性缺血性脑卒中合并上肢动脉栓塞三例救治分析[J].中华危重症医学杂志(电子版),2022,15(5):399-404. 被引量:1
-
6龚冰璐,黄红漫.心房颤动的基础研究和临床治疗新进展[J].心血管病学进展,2006,27(z1):106-108.
-
7赵琼琼,柳茵.高血压伴心房颤动患者脑钠肽的变化与肾素血管紧张素醛固酮系统的关系[J].青海医药杂志,2008,38(4):1-3. 被引量:3
-
8杜昕,胡荣,康俊萍,韩智红,刘晓惠,董建增,马长生.心房颤动门诊病例的调查[J].中国心脏起搏与心电生理杂志,2004(z1).
-
9舒燕,陈晓平.血管紧张素受体拮抗剂对心房纤颤的影响[J].华西医学,2008,23(5):1201-1202. 被引量:2
-
10马希,孙飞,李莉娟,陶四明.心房纤颤56例口服华法林的护理[J].中国误诊学杂志,2009,9(5):1174-1175.
同被引文献26
-
1王海彦.非瓣膜性房颤并发脑栓塞的临床观察[J].现代医药卫生,2005,21(7):810-810. 被引量:5
-
2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33150
-
3OOSTEROM A V, LEMAY M, KAPPENBERGER L. Full spectral analysis of the atrial components in the ECG during atrial aibrillation [M]//Computer in Cardiology 2008. Washington: IEEE Computer Society Press, 2008: 817-820.
-
4VAYA C, RIETA J J, SANCHEZ C, etal. Convolutive blind source separation algorithms applied to the electrocardiogram of atrial fibrillation: study of performance [J]. IEEE Transactions on Biomedical Engineering, 2007, 54(8): 1530-1533.
-
5CASTELLS F, RIETA J J, MILLET J, et al. Spatiotemporal blind source separation approach to atrial activity estimation in atrial tachyarrhythmias [ J ]. IEEE Transactions on Biomedical Engineering, 2005, 52(2): 258-267.
-
6ALCARAZ R, RIETA J J. Optimal beat selection study for QSRT cancellation methods in the ECG of atrial fibrillation [ M ]//Computer in Cardiology 2008. Washington: IEEE Computer Society Press, 2008: 1045-1048.
-
7SANCHEZ C, MILLER J, RIETA J J, et al. Packet wavelet decomposition: an approach for atrial activity extraction [ J ]. IEEE Computers in Cardiology, 2002, 29: 33-36.
-
8COMON P. Independent component analysis: a new concept[J]. Signal Processing, 1994, 36(3): 287- 314.
-
9STRIDH M, SORNMO L. Spatiotemporal QRST cancellation techniques for analysis of atrial fibrillation[J]. IEEE Transactions on Biomedical Engineering, 2001, 48(1) : 105-111.
-
10VAYA C, RIETA J J, ALCARAZ R. Convolutive multiband blind separation to dissociate atrial from ventricular activity in atrial fibrillation [M]// Computer in Cardiology 2009. Washington: IEEE Computer Society Press, 2009: 713-716.
引证文献3
-
1林土胜,陈国豪.基于小波变换和ICA的房颤信号分离[J].西北师范大学学报(自然科学版),2010,46(5):34-39.
-
2易晓淑,章丽萍,孙慧超.应用低分子肝素钠预防房颤患者住院期间心源性脑栓塞的临床研究[J].中国医药导报,2013,10(20):149-150. 被引量:10
-
3苗靖文,郭涛.探讨非瓣膜性心房颤动的抗凝治疗[J].中国医药科学,2016,6(19):55-57. 被引量:2
二级引证文献12
-
1张纯桥.人尿激肽原酶滴注治疗心源性脑栓塞患者疗效观察[J].医学信息(医学与计算机应用),2016,29(31):58-59.
-
2Zheng Huang,Xiao-Chen Wang,Jian-Long Sheng,Fei He,Cheng Cheng,Chao-Hui Zhang,Bang-Long Xu.Analysis of atrial remodeling, fibrosis, oxidative stress and insulin resistance levels in patients with atrial fibrillation[J].Journal of Hainan Medical University,2019,25(3):52-55.
-
3张浩,冯琳琳.基因指导的华法林用药研究[J].中国医药导报,2014,11(25):151-154. 被引量:2
-
4安惠娟,王慧.超早期溶栓联合早期降颅压用于房颤致完全前循环型脑栓塞中的价值[J].中国现代药物应用,2015,9(8):115-116. 被引量:1
-
5郭玉君,杨峰,赵利,艾力曼.马合木提,张玲.房颤的危险因素及其对心肌重构的影响研究[J].中国医药导报,2016,13(5):55-58. 被引量:13
-
6范存秀.低分子肝素钙治疗急性期非大面积心源性脑栓塞的临床效果观察[J].湖南中医药大学学报,2016,36(A01):116-116. 被引量:1
-
7黄春,朱飞,胡细灰.阿加曲班联合依达拉奉治疗心房颤动合并脑栓塞的临床效果[J].中国当代医药,2016,23(36):39-41. 被引量:4
-
8李雪花.低分子肝素联合银杏达莫治疗急性心源性脑栓塞患者的临床疗效及安全性分析[J].中国药物经济学,2017,12(3):79-81. 被引量:2
-
9张琳,陈艳炯,吴柏云,刘军辉,洪舟,李娜,封婧,陶丹.左心房内径、超敏C反应蛋白、脑尿钠肽与老年非瓣膜性心房颤动的关系[J].中国医药导报,2018,15(35):66-69. 被引量:6
-
10杨雯,李满连.低分子肝素钠治疗急性期非大面积心源性脑栓塞的临床效果[J].中国当代医药,2018,25(36):90-92. 被引量:1
-
1赵怀美.非瓣膜性心房颤动抗凝治疗疗效和安全性观察[J].中国美容医学,2012,21(09X):150-151. 被引量:4
-
2张源,王群山.达比加群酯在器质性心脏病的心房颤动中的应用进展[J].心血管病学进展,2016,37(1):27-31. 被引量:1
-
3耿清峰,杨洪霞,田锐.心房颤动抗凝治疗的现状[J].医师进修杂志,2004,27(1):48-49. 被引量:3
-
4闫国平.卒中/栓塞危险因素及心房颤动抗凝治疗合并症的探讨[J].国外医学(内科学分册),2003,30(2):88-88.
-
5钟东.心房颤动抗凝治疗的进展[J].蛇志,2010,22(3):257-260. 被引量:2
-
6周京敏.心房颤动抗凝治疗进展[J].内科理论与实践,2012,7(5):341-343.
-
7智光,冷文修.心房颤动抗凝治疗研究进展[J].人民军医,2006,49(8):458-461. 被引量:1
-
8丁敏.腹膜透析患者并发心房颤动抗凝治疗临床研究[J].临床医学,2007,27(2):39-40.
-
9陈尧飞.华法林在老年心房颤动抗凝治疗中的疗效分析[J].中国医药指南,2014,12(1):107-108. 被引量:2
-
10化冰,李卫萍,李虹伟.心房颤动抗凝治疗进展[J].心血管病学进展,2014,35(6):660-664. 被引量:10